CJC-1295 w/ DAC
CJC-1295 w/ DAC is a long-acting modified GHRH analog with Drug Affinity Complex for extended half-life. Preclinical studies investigate its stimulation of growth hormone secretion in laboratory models.
Key Research Areas
- • Studied for GHRH-mediated GH and IGF-1 elevation with prolonged action in research models.
- • Investigated for sustained GH secretion profiles due to albumin binding via DAC.
- • Explored for modulation of growth hormone axis signaling in laboratory metabolic research.
Product Specifications
| Product |
CJC-1295 w/ DAC |
| CAS Number |
446262-90-4 |
| Molecular Formula |
Modified GHRH analog with Drug Affinity Complex (DAC) |
| Molar Mass |
~5 kDa range (core + DAC) |
| Sequence |
Modified GHRH(1-29) analog with Drug Affinity Complex attachment for extended half-life |
| Synonyms |
CJC-1295 with DAC; DAC:GRF |
| Purity |
≥99% (HPLC) |
| Form |
Lyophilized powder |
| Storage |
−20°C (−4°F) long-term; 2–8°C (36–46°F) reconstituted |
| Solubility |
Bacteriostatic water for laboratory use |
All products offered by Premier Research are intended for laboratory research use only. These materials are not for human or veterinary consumption, medical use, diagnostic procedures, or therapeutic applications. Statements on this website are for informational and educational purposes only and have not been evaluated by the U.S. Food and Drug Administration (FDA). By accessing this site, you confirm that you are a qualified researcher or institution representative and agree to use all materials in accordance with applicable laws, regulations, and safety guidelines.
